Physician profile
Ryan Chin
NPI 1407317829
$3,248.12
in general payments reported to CMS, 2019-2025
10 companies · $3,202 in 2025
The $3,202 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $45.86 · 2025: $3,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,318 · Travel and Lodging: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,318.41 |
| Travel and Lodging | $429.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2025 | |
| W. L. Gore & Associates, INC. | $886.80 | 2025 | Gore Enform Preperitoneal Biomaterial, Gore Enform Intraperitoneal Biomaterial |
| Davol INC. | $195.62 | 2025 | Phasix Mesh |
| Medtronic, INC. | $162.16 | 2025 | Progrip, Ligasure |
| Baxter Healthcare | $151.31 | 2025 | Tisseel |
| Solventum Corporation | $150.00 | 2025 | Prevena |
| Teleflex LLC | $122.37 | 2025 | Titan Sgs Bailout Chuck |
| Janssen Biotech, INC. | $34.00 | 2025 | Tremfya, Stelara, Simponi |
| Tactile Systems Technology INC | $24.52 | 2024 | Entre Plus, Flexitouch Plus |
| Phathom Pharmaceuticals, INC. | $21.34 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.